Fortrea completes acquisition of Worldwide Clinical Trials’ Early Phase Services division

Fortrea completed its approximately $45M all-cash acquisition of Worldwide Clinical Trials’ Early Phase Services division, adding a 200-bed CRU, a 60,000 sq ft bioanalytical lab, and a biospecimen storage facility in Texas.Material DetailsContext by AI AnalystThis is a mid-cycle bolt-on aimed at re…